OPFOLDA
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for OPFOLDA, covering 2023-09-28 to 2025-02-14. Get the full timeline:
Most recent: EMA Authorised: Opfolda (miglustat) — Amicus Therapeutics Europe Limited